{
  "title": "Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease",
  "guid": "FD51E7801E2A19190C8D1AD5",
  "filepath": "/sessions/bold-jolly-cerf/mnt/Dropbox/- Esquemas/- Entidades clínicas/Cardiología/Antagonstas del receptor de Orexina-2025.smmx",
  "root": {
    "id": "0",
    "parent": "-1",
    "text": "Orexin Receptor Antagonism: Normalizing\nSleep Architecture in Old Age and Disease",
    "guid": "f_NxDiWNLqzfj5tFsaAt7A",
    "children": [
      {
        "id": "1",
        "parent": "0",
        "text": "1. Introducción",
        "guid": "",
        "children": [
          {
            "id": "2",
            "parent": "1",
            "text": "• Sueño: Esencial para bienestar humano.",
            "guid": "_8U0MkA4Tc1FcrB84UL2Xg",
            "children": []
          },
          {
            "id": "3",
            "parent": "1",
            "text": "• Alteraciones en vejez: ↓Calidad y cantidad sueño (>65 años) → ↑Riesgo de enfermedades asociadas.",
            "guid": "bGH2SKs5YbKyGQ-0uUJ4aw",
            "children": []
          },
          {
            "id": "4",
            "parent": "1",
            "text": "• Relación bidireccional: Sueño alterado ↔ Alzheimer (AD) y demencias relacionadas.",
            "guid": "uTe2yMp-lo3OAg91aS974g",
            "children": []
          }
        ]
      },
      {
        "id": "5",
        "parent": "0",
        "text": "2. Sistema\nOrexin/Hypocretin",
        "guid": "",
        "children": [
          {
            "id": "6",
            "parent": "5",
            "text": "• Función: Estabiliza vigilia.",
            "guid": "cY3tfNWTmV7VuKbTZe9d8w",
            "children": []
          },
          {
            "id": "7",
            "parent": "5",
            "text": "• Disregulación: Asociada a envejecimiento y AD.",
            "guid": "Rxgpz0DH2trn38ANlTxLxQ",
            "children": []
          },
          {
            "id": "8",
            "parent": "5",
            "text": "• Terapia: Antagonistas de receptores orexina (ORAs).",
            "guid": "YZX0NCCThW-bTd_VMcpK0w",
            "children": []
          }
        ]
      },
      {
        "id": "9",
        "parent": "0",
        "text": "3. Antagonistas de\nReceptores Orexina (ORAs)",
        "guid": "",
        "children": [
          {
            "id": "10",
            "parent": "9",
            "text": "• Ejemplos: Suvorexant, Lemborexant, Daridorexant.",
            "guid": "7MVQguo3achlWeLmans7Xw",
            "children": []
          },
          {
            "id": "11",
            "parent": "9",
            "text": "• Indicación: Tratamiento de insomnio en adultos y adultos mayores.",
            "guid": "TFmYRr72MvIzAXhDan6Mgg",
            "children": []
          },
          {
            "id": "12",
            "parent": "9",
            "text": "• Mecanismo:",
            "guid": "",
            "children": [
              {
                "id": "13",
                "parent": "12",
                "text": "• Bloquean receptores orexina → ↓Vigilia → ↑Arquitectura del sueño.",
                "guid": "8XS24bK9KhaLMdBJJd0R-Q",
                "children": []
              }
            ]
          },
          {
            "id": "14",
            "parent": "9",
            "text": "• Evidencia en\nmayores:",
            "guid": "Erb4_yVOtw2bOh5cFreyxA",
            "children": [
              {
                "id": "15",
                "parent": "14",
                "text": "• Eficacia: Mejora sueño en >65 años y pacientes con demencia.",
                "guid": "2I3wzE1J9viIdxxJXzx2OA",
                "children": []
              },
              {
                "id": "16",
                "parent": "14",
                "text": "• Tolerancia: Generalmente bien tolerados.",
                "guid": "6O2sEzfRwdG_KZI1alxZ5g",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "17",
        "parent": "0",
        "text": "4. Beneficios en Adultos\nMayores y Demencia",
        "guid": "",
        "children": [
          {
            "id": "18",
            "parent": "17",
            "text": "• Inicio temprano: +Eficacia en fases iniciales de alteraciones sueño/vigilia.",
            "guid": "QZfUsnls-8ZRYxMmTqB3OA",
            "children": []
          },
          {
            "id": "19",
            "parent": "17",
            "text": "• Efectos secundarios: Generales pero controlados.",
            "guid": "XyYayKJ2ygogERvJ_slLOg",
            "children": []
          },
          {
            "id": "20",
            "parent": "17",
            "text": "• Impacto:",
            "guid": "",
            "children": [
              {
                "id": "21",
                "parent": "20",
                "text": "• Reestablece patrones sueño/vigilia.",
                "guid": "uXNVVawohw-tw5iAgjRxoQ",
                "children": []
              },
              {
                "id": "22",
                "parent": "20",
                "text": "• ↓Acumulación de sustratos patológicos asociados a demencia (p. ej., beta-amiloide).",
                "guid": "35B4CG5nBW36jFbvoc5tbw",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "23",
        "parent": "0",
        "text": "5. Implicancias\nClínicas",
        "guid": "mxWtbc7zcFDCjp5XmGqlZw",
        "children": [
          {
            "id": "24",
            "parent": "23",
            "text": "• Oportunidad\nterapéutica:",
            "guid": "orCR4WzjWUyB_TaFRrdPHg",
            "children": [
              {
                "id": "25",
                "parent": "24",
                "text": "• Mejora bienestar pacientes, cuidadores y sistemas de salud.",
                "guid": "rN0EiH96fsNucfl9Wgg89g",
                "children": []
              },
              {
                "id": "26",
                "parent": "24",
                "text": "• Uso temprano en envejecimiento → ↓Carga asociada a demencia.",
                "guid": "to8kQcqwhFu78ozmZHb-lw",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "27",
        "parent": "0",
        "text": "INTRODUCCIÓN: Regulación del sueño\ny el sistema orexina/hypocretina",
        "guid": "AmZNutENaBVsSUGR2cHMRw",
        "children": [
          {
            "id": "28",
            "parent": "27",
            "text": "1. Importancia\ndel sueño",
            "guid": "maFQHrJ8GeJl__E-sGF8-g",
            "children": [
              {
                "id": "29",
                "parent": "28",
                "text": "• Función: Conservación salud física y mental (1).",
                "guid": "W7jj7akUbzRDWXyypqE6fA",
                "children": []
              },
              {
                "id": "30",
                "parent": "28",
                "text": "• Alteraciones modernas: ↓Cantidad/calidad sueño (2).",
                "guid": "pByy0uav4yaZWWyQ-DXiRA",
                "children": []
              },
              {
                "id": "31",
                "parent": "28",
                "text": "• Impacto\nen vejez:",
                "guid": "rB2S43ReHg7zr07CX63umQ",
                "children": [
                  {
                    "id": "32",
                    "parent": "31",
                    "text": "• Relación edad → ↑Vulnerabilidad a pérdida/disregulación del sueño (3).",
                    "guid": "kBNPRHfFe0RIgi5BqsPp0w",
                    "children": []
                  },
                  {
                    "id": "33",
                    "parent": "31",
                    "text": "• Países desarrollados → ↑Población >65 años (4).",
                    "guid": "zqtOkRAKydsBVdUNdmLiRw",
                    "children": []
                  },
                  {
                    "id": "34",
                    "parent": "31",
                    "text": "• Asociaciones: ↑Problemas de salud relacionados con sueño deficiente (5).",
                    "guid": "ppSnrNeup81nuZ7lafia4w",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "35",
            "parent": "27",
            "text": "2. Necesidad en\npoblación mayor",
            "guid": "JjHB96gR0POj5yx3LC6w3Q",
            "children": [
              {
                "id": "36",
                "parent": "35",
                "text": "• Desafío: Mejorar manejo de alteraciones del sueño en >65 años.",
                "guid": "Ma1y0gOPI8Y-APkC5kA_yw",
                "children": []
              }
            ]
          },
          {
            "id": "37",
            "parent": "27",
            "text": "3. Sistema\norexina/hypocretina",
            "guid": "iAuScZoiOZMoDHmyRnmcZQ",
            "children": [
              {
                "id": "38",
                "parent": "37",
                "text": "• Rol: Regula ciclo sueño/vigilia.",
                "guid": "UMvbIkmLpfrz7bDSwn-NOg",
                "children": []
              },
              {
                "id": "39",
                "parent": "37",
                "text": "• Disfunción: Contribuye a trastornos del sueño.",
                "guid": "VCPYJ-x1lsDZ2WEQT6M0-Q",
                "children": []
              }
            ]
          },
          {
            "id": "40",
            "parent": "27",
            "text": "4. Antagonistas de\nreceptores orexina (ORAs)",
            "guid": "aL72hgkmEwaPUdIY1Rl_XQ",
            "children": [
              {
                "id": "41",
                "parent": "40",
                "text": "• Efecto\nterapéutico:",
                "guid": "DRdmrrhwEk0g3cwlktM1KQ",
                "children": [
                  {
                    "id": "42",
                    "parent": "41",
                    "text": "• Promueven sueño eficazmente.",
                    "guid": "ZwgOUwKAeXWH08RoDCk_SQ",
                    "children": []
                  },
                  {
                    "id": "43",
                    "parent": "41",
                    "text": "• Mantienen/↑Arquitectura del sueño saludable (incl. REM).",
                    "guid": "E3Aa1VSDZyIaA-RU46M_xg",
                    "children": []
                  }
                ]
              },
              {
                "id": "44",
                "parent": "40",
                "text": "• Ventajas:",
                "guid": "",
                "children": [
                  {
                    "id": "45",
                    "parent": "44",
                    "text": "• ↓Efectos adversos comparados con hipnóticos tradicionales.",
                    "guid": "mEec9aEIZL3rAeNdWBsT4A",
                    "children": []
                  },
                  {
                    "id": "46",
                    "parent": "44",
                    "text": "• Sin riesgo de adicción o tolerancia (6, 7).",
                    "guid": "Db667nKXvKbBanWJcAeWmA",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "47",
            "parent": "27",
            "text": "5. Beneficio en\nenvejecimiento",
            "guid": "_wlOJuhonmsFsU140zMyDg",
            "children": [
              {
                "id": "48",
                "parent": "47",
                "text": "• Impacto\npositivo:",
                "guid": "5zTXO_B-eltmoWbGJrzoyQ",
                "children": [
                  {
                    "id": "49",
                    "parent": "48",
                    "text": "• Mejoran bienestar físico y mental.",
                    "guid": "gqtcrKXgK9rIPJi85G-P9Q",
                    "children": []
                  },
                  {
                    "id": "50",
                    "parent": "48",
                    "text": "• Posicionamiento como opción terapéutica transformadora en adultos y población mayor.",
                    "guid": "HWFKOxRUFvxtaYLKOF9zdQ",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "id": "51",
        "parent": "0",
        "text": "Bases del sueño y\nsus procesos",
        "guid": "2elk7Ym7Z9v1tS_OEBJEnA",
        "children": [
          {
            "id": "52",
            "parent": "51",
            "text": "1. Definición\nde sueño",
            "guid": "i0bd2FApdeC7u9QI27W-Ng",
            "children": [
              {
                "id": "53",
                "parent": "52",
                "text": "• Estado alterado de conciencia: ↓Actividad motora y respuesta a estímulos.",
                "guid": "NVW0ScTKjI-UP9LkEFzexg",
                "children": []
              },
              {
                "id": "54",
                "parent": "52",
                "text": "• Comportamiento conservado: Común en mamíferos y nematodos.",
                "guid": "u_khgw0In4Mibegi83SUTg",
                "children": []
              },
              {
                "id": "55",
                "parent": "52",
                "text": "• Relación\ncon salud:",
                "guid": "TCH46h75k9dT1gOsTmL5Dg",
                "children": [
                  {
                    "id": "56",
                    "parent": "55",
                    "text": "• Cognición (8, 9).",
                    "guid": "ps8lIspcSu4oxIp3Yfspmg",
                    "children": []
                  },
                  {
                    "id": "57",
                    "parent": "55",
                    "text": "• Regulación endócrina (10).",
                    "guid": "kRa2JeuW_o5mE81EtPIffQ",
                    "children": []
                  },
                  {
                    "id": "58",
                    "parent": "55",
                    "text": "• Reparación tisular (11).",
                    "guid": "pW0GUhCdd_uKSCfGAtSEWQ",
                    "children": []
                  },
                  {
                    "id": "59",
                    "parent": "55",
                    "text": "• Estado inmune (12–14).",
                    "guid": "TqwX5wc9btZ15KAGTpqU0Q",
                    "children": []
                  },
                  {
                    "id": "60",
                    "parent": "55",
                    "text": "• Reparación neuronal (15).",
                    "guid": "RyAzyxXIfsynM9cIyCy1Vg",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "61",
            "parent": "51",
            "text": "2. Evaluación\ndel sueño",
            "guid": "pRw6oaKtb_qSX5w3XBnMsA",
            "children": [
              {
                "id": "62",
                "parent": "61",
                "text": "• Polisomnografía (PSG):",
                "guid": "",
                "children": [
                  {
                    "id": "63",
                    "parent": "62",
                    "text": "• Herramienta estándar.",
                    "guid": "AHdFxUU9zUqfDzY0yqQtPQ",
                    "children": []
                  },
                  {
                    "id": "64",
                    "parent": "62",
                    "text": "• Biomarcadores: EEG (cerebro), EMG (músculos), EOG (ojos).",
                    "guid": "FhOuolVwqvA86q3MgcectA",
                    "children": []
                  }
                ]
              },
              {
                "id": "65",
                "parent": "61",
                "text": "• Clasificación\nEEG:",
                "guid": "Rqt9aKjzXqk8qVGrOhQw0Q",
                "children": [
                  {
                    "id": "66",
                    "parent": "65",
                    "text": "• Gamma (31–100 Hz).",
                    "guid": "PxHVG-2z-v6Bh0vHc508Nw",
                    "children": []
                  },
                  {
                    "id": "67",
                    "parent": "65",
                    "text": "• Beta (13–30 Hz).",
                    "guid": "uKwrzyjAdEKu-90TBc_9lQ",
                    "children": []
                  },
                  {
                    "id": "68",
                    "parent": "65",
                    "text": "• Alpha (8–13 Hz).",
                    "guid": "l9wfPJCUzDdSKJP7n4MeGA",
                    "children": []
                  },
                  {
                    "id": "69",
                    "parent": "65",
                    "text": "• Theta (4–7 Hz).",
                    "guid": "sPgm5jIzesFsGIUeYPKAQg",
                    "children": []
                  },
                  {
                    "id": "70",
                    "parent": "65",
                    "text": "• Delta (0.1–4 Hz).",
                    "guid": "S2OutZJtV_-f3SmLoggaLg",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "71",
            "parent": "51",
            "text": "3. Ciclos del\nsueño humano",
            "guid": "AiYXhVT5MMZ2fom8P4OJOQ",
            "children": [
              {
                "id": "72",
                "parent": "71",
                "text": "• Fases del sueño\n(NREM y REM):",
                "guid": "",
                "children": [
                  {
                    "id": "73",
                    "parent": "72",
                    "text": "• NREM:",
                    "guid": "Ge82-eo93lAW0W5zxbKG6A",
                    "children": [
                      {
                        "id": "74",
                        "parent": "73",
                        "text": "• N1: ↑Alpha, ↑Theta; ↓Actividad muscular.",
                        "guid": "OeyF3wRdhS2_-uS3tdOm7A",
                        "children": []
                      },
                      {
                        "id": "75",
                        "parent": "73",
                        "text": "• N2: ↑Theta, ↑Delta; ↓Temperatura y FR;\npresencia de husos de sueño y complejos K.",
                        "guid": "qAzitm8tN8JIJeL2fhLD8w",
                        "children": []
                      },
                      {
                        "id": "76",
                        "parent": "73",
                        "text": "• N3: ↑Delta (sueño de ondas\nlentas/SWS); sincronización cortical alta.",
                        "guid": "PhDgUrvdKR5pFlrsVQv0VA",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "77",
                    "parent": "72",
                    "text": "• REM:",
                    "guid": "v0cPgZmqZzSPRq4v9J0kEQ",
                    "children": [
                      {
                        "id": "78",
                        "parent": "77",
                        "text": "• EEG similar a vigilia.",
                        "guid": "tCpkkT5AckAsgYb5Z34W-A",
                        "children": []
                      },
                      {
                        "id": "79",
                        "parent": "77",
                        "text": "• Atonía muscular periférica.",
                        "guid": "YY1zl-x6C8BQ5VGUDSCs0w",
                        "children": []
                      },
                      {
                        "id": "80",
                        "parent": "77",
                        "text": "• ↑Movimientos oculares rápidos.",
                        "guid": "HRmyQ_Rz5_keQ3JIXPbfqw",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "81",
                "parent": "71",
                "text": "• Ciclo típico: N1 > N2 > N3 > N2 > REM\n(duración ≈90 min).",
                "guid": "mdydy5d2VtwUXTpFDExeLQ",
                "children": []
              }
            ]
          },
          {
            "id": "82",
            "parent": "51",
            "text": "4. Regulación\ndel sueño",
            "guid": "6DILHpHtAeIbLJXSLRnRTw",
            "children": [
              {
                "id": "83",
                "parent": "82",
                "text": "• Modelo de\ndos procesos:",
                "guid": "",
                "children": [
                  {
                    "id": "84",
                    "parent": "83",
                    "text": "• Proceso S\n(homeostático):",
                    "guid": "bGaS0cozSTYHl5360lxPlA",
                    "children": [
                      {
                        "id": "85",
                        "parent": "84",
                        "text": "• ↑Sustancias somnogénicas → ↑Presión de sueño.",
                        "guid": "AuSAN2R0M8N2woT128iQGQ",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "86",
                    "parent": "83",
                    "text": "• Proceso C\n(circadiano):",
                    "guid": "OHqTG8-EzQH4JMEyByDN_g",
                    "children": [
                      {
                        "id": "87",
                        "parent": "86",
                        "text": "• Regulación por núcleo supraquiasmático (SCN) y luz/oscuridad.",
                        "guid": "7wbm1MSrJb_RGc6m3Fh5Wg",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "id": "88",
            "parent": "51",
            "text": "5. Neuroanatomía y\nneuroquímica",
            "guid": "cL7eMEkAtX8XRB6O5lEyrQ",
            "children": [
              {
                "id": "89",
                "parent": "88",
                "text": "• Sistemas de\npromoción de vigilia:",
                "guid": "",
                "children": [
                  {
                    "id": "90",
                    "parent": "89",
                    "text": "• ARAS:",
                    "guid": "yaJF8iSXJUY8NTY-pAWf8Q",
                    "children": [
                      {
                        "id": "91",
                        "parent": "90",
                        "text": "• Vía dorsal → Tálamo → Corteza.",
                        "guid": "x1gSTPU5tcRy3UrUrU1LVQ",
                        "children": []
                      },
                      {
                        "id": "92",
                        "parent": "90",
                        "text": "• Vía ventral → Hipotálamo y tronco encefálico.",
                        "guid": "WT-5jlIVmwSFUaBDa23Tqg",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "93",
                    "parent": "89",
                    "text": "• Núcleos\nmonoaminérgicos:",
                    "guid": "I89NJwhtBGiCZzfjTshMUA",
                    "children": [
                      {
                        "id": "94",
                        "parent": "93",
                        "text": "• LC (NA), DRN (5-HT), TMN (histamina).",
                        "guid": "Wc6srqiXEaAkp2f-Dkz1fQ",
                        "children": []
                      },
                      {
                        "id": "95",
                        "parent": "93",
                        "text": "• Regiones colinérgicas: BF, PPT, LDT.",
                        "guid": "Hf1ZyJp1MaLfKM8d9CndJQ",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "96",
                "parent": "88",
                "text": "• Centros de\npromoción de\nsueño:",
                "guid": "",
                "children": [
                  {
                    "id": "97",
                    "parent": "96",
                    "text": "• VLPO, MnPO\n(GABA/galanina).",
                    "guid": "ArHZTUP8PFip08OSwy3K2A",
                    "children": []
                  },
                  {
                    "id": "98",
                    "parent": "96",
                    "text": "• Zonas parafaciales\n(GABA).",
                    "guid": "3NWcR0YUlcORzwVsi_e9-g",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "99",
            "parent": "51",
            "text": "6. Alteraciones en\nadultos mayores",
            "guid": "loR7dL8bDsjsie83gNzz1Q",
            "children": [
              {
                "id": "100",
                "parent": "99",
                "text": "• Sueño fragmentado: ↑Latencia,\n↓SWS, ↑Despertares (WASO).",
                "guid": "",
                "children": []
              },
              {
                "id": "101",
                "parent": "99",
                "text": "• ↓Amplitud de procesos S y C:\nCambios en arquitectura del sueño.",
                "guid": "",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "102",
        "parent": "0",
        "text": "Orexina y receptores\nde orexina",
        "guid": "88itZZEXWMiLM1rN9v-_1A",
        "children": [
          {
            "id": "103",
            "parent": "102",
            "text": "1. Sistema\norexina/hypocretina",
            "guid": "FJkcm3luiVIaawR31DCAZw",
            "children": [
              {
                "id": "104",
                "parent": "103",
                "text": "• Descubrimiento: Neuropeptido asociado a transición\ny estabilización del ciclo sueño/vigilia (34, 35).",
                "guid": "68vgow6jqJAzUPhG9xjCjg",
                "children": []
              },
              {
                "id": "105",
                "parent": "103",
                "text": "• Terminología:",
                "guid": "",
                "children": [
                  {
                    "id": "106",
                    "parent": "105",
                    "text": "• Orexina: Producto proteico.",
                    "guid": "GjydHTm5Uuh8XgBrtjMhew",
                    "children": []
                  },
                  {
                    "id": "107",
                    "parent": "105",
                    "text": "• Hipocretina: Producto génico (36).",
                    "guid": "vwxjLOvxr-sjITbycyWyig",
                    "children": []
                  }
                ]
              },
              {
                "id": "108",
                "parent": "103",
                "text": "• Composición:",
                "guid": "",
                "children": [
                  {
                    "id": "109",
                    "parent": "108",
                    "text": "• Péptidos: OX-A, OX-B.",
                    "guid": "XL6fR4ae-MYeOYmo-erkYg",
                    "children": []
                  },
                  {
                    "id": "110",
                    "parent": "108",
                    "text": "• Precursos: Prepro-orexina (PPO).",
                    "guid": "VxPOpVUPaNVzcu3VliIspA",
                    "children": []
                  },
                  {
                    "id": "111",
                    "parent": "108",
                    "text": "• Producción: Neuronas LH (hipotálamo lateral).",
                    "guid": "serko0o7glpog_659WQX4Q",
                    "children": []
                  },
                  {
                    "id": "112",
                    "parent": "108",
                    "text": "• Receptores: OX1R y OX2R (acoplados a proteína G).",
                    "guid": "Zl2FmhJlYlI6IFn8D9Xmig",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "113",
            "parent": "102",
            "text": "2. Función del\nsistema orexinérgico",
            "guid": "bCZm5bGKr2VnprcobzIqQA",
            "children": [
              {
                "id": "114",
                "parent": "113",
                "text": "• Neuronal:",
                "guid": "",
                "children": [
                  {
                    "id": "115",
                    "parent": "114",
                    "text": "• Neuronas activas en vigilia y exploración activa; inactivas en sueño (39).",
                    "guid": "i168yJ3i3SfwhBkoqdEpXA",
                    "children": []
                  },
                  {
                    "id": "116",
                    "parent": "114",
                    "text": "• Innervación extensa: regiones monoaminérgicas, tálamo y corteza (40, 41).",
                    "guid": "yI-7iMO50Srst4EvrqyceA",
                    "children": []
                  }
                ]
              },
              {
                "id": "117",
                "parent": "113",
                "text": "• Excitación:",
                "guid": "",
                "children": [
                  {
                    "id": "118",
                    "parent": "117",
                    "text": "• Activa regiones colinérgicas y monoaminérgicas → Inhibe centros promotores de sueño.",
                    "guid": "08Llffnhec9fHOZABQZkOw",
                    "children": []
                  },
                  {
                    "id": "119",
                    "parent": "117",
                    "text": "• ↓Tono orexinérgico → ↑Activación circuitos promotores de sueño → Inicio de sueño.",
                    "guid": "OPcXDc-CPoGdSLrMwLSZjQ",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "120",
            "parent": "102",
            "text": "3. Mecanismo de transición\nsueño/vigilia (modelo flip-flop)",
            "guid": "JTwjGvNFkwFjo_sZzOqcHw",
            "children": [
              {
                "id": "121",
                "parent": "120",
                "text": "• Flip-flop vigilia-sueño:",
                "guid": "",
                "children": [
                  {
                    "id": "122",
                    "parent": "121",
                    "text": "• ON (vigilia): ↑Orexina → Inhibición promotores del sueño.",
                    "guid": "nTkRED1f1_YgLTmAwC9gBQ",
                    "children": []
                  },
                  {
                    "id": "123",
                    "parent": "121",
                    "text": "• OFF (sueño): ↓Orexina → Activación circuitos del sueño.",
                    "guid": "tpKqwnxyHt0WunXMNAW8Kw",
                    "children": []
                  }
                ]
              },
              {
                "id": "124",
                "parent": "120",
                "text": "• Flip-flop NREM-REM:",
                "guid": "",
                "children": [
                  {
                    "id": "125",
                    "parent": "124",
                    "text": "• NREM:",
                    "guid": "JaBB__JIm3BIH_xZsQrmhg",
                    "children": [
                      {
                        "id": "126",
                        "parent": "125",
                        "text": "• Regulado por VLPO, MnPO, PZ, vlPAG y LPT.",
                        "guid": "GsVD7B2oq2mhn-N-0LcwJA",
                        "children": []
                      },
                      {
                        "id": "127",
                        "parent": "125",
                        "text": "• vlPAG/LPT inhiben inicio de REM.",
                        "guid": "WIU-4lAbEaddmJcFiQ0axg",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "128",
                    "parent": "124",
                    "text": "• REM:",
                    "guid": "8xdvlOEYG4-uvepNBMIsKA",
                    "children": [
                      {
                        "id": "129",
                        "parent": "128",
                        "text": "• Neuronas GABAérgicas (SLD) inhiben NREM y activan REM.",
                        "guid": "nRZxCrfkR3l1bkGm4Ca5ZQ",
                        "children": []
                      },
                      {
                        "id": "130",
                        "parent": "128",
                        "text": "• Inhibición recíproca contribuye al switch NREM-REM (42).",
                        "guid": "mbKS0bRSqrvJy5DBHTE1TA",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "id": "131",
            "parent": "102",
            "text": "4. Modulación\nmonoaminérgica y\ncolinérgica",
            "guid": "caO_Ua1naBUxLe7Txx6TCw",
            "children": [
              {
                "id": "132",
                "parent": "131",
                "text": "• Monoaminas: LC (NA), DR (5-HT).",
                "guid": "MOZ47k8NfkFXVUF-llXhOQ",
                "children": []
              },
              {
                "id": "133",
                "parent": "131",
                "text": "• Excitan circuitos REM-off; ↓Actividad en REM.",
                "guid": "bggTJNOmihxe2l_sWJAIEA",
                "children": []
              },
              {
                "id": "134",
                "parent": "131",
                "text": "• Colinérgico: LDT excita REM-on e inhibe REM-off.",
                "guid": "JsMNxmzxx2FbteFk4CBW7w",
                "children": []
              },
              {
                "id": "135",
                "parent": "131",
                "text": "• Impacto en sueño total: Mínimo; lesiones no alteran significativamente el ciclo sueño/vigilia (43–45).",
                "guid": "2BUecmsrZja1VKRVtRXTXA",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "136",
        "parent": "0",
        "text": "Mutaciones genéticas en\nroedores y narcolepsia",
        "guid": "WDOBfMLCi4Tkr0WYULwxbQ",
        "children": [
          {
            "id": "137",
            "parent": "136",
            "text": "1. Modelo en ratones\nKO (Knockout)",
            "guid": "oOPbFW5l4v5Kd7S-bDe5Ow",
            "children": [
              {
                "id": "138",
                "parent": "137",
                "text": "• OX1R KO:",
                "guid": "",
                "children": [
                  {
                    "id": "139",
                    "parent": "138",
                    "text": "• Sin alteraciones significativas en sueño (52).",
                    "guid": "CLILgIWKfNduC5_hQD8Xxw",
                    "children": []
                  }
                ]
              },
              {
                "id": "140",
                "parent": "137",
                "text": "• OX2R KO:",
                "guid": "",
                "children": [
                  {
                    "id": "141",
                    "parent": "140",
                    "text": "• Fenotipo:",
                    "guid": "xez7HsCbKQB5yVT_FKa7UQ",
                    "children": [
                      {
                        "id": "142",
                        "parent": "141",
                        "text": "• Alteraciones marcadas del sueño.",
                        "guid": "Vug2upWs5vxzbVjfZi6UHA",
                        "children": []
                      },
                      {
                        "id": "143",
                        "parent": "141",
                        "text": "• Algunos episodios de cataplejía.",
                        "guid": "oFHAC8kTOArZgURc1Qg4bg",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "144",
                "parent": "137",
                "text": "• Doble KO\n(OX1R + OX2R):",
                "guid": "",
                "children": [
                  {
                    "id": "145",
                    "parent": "144",
                    "text": "• Fenotipo similar a NT1 humano (52).",
                    "guid": "4-87qynfM7wYGDuQu4AVhw",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "146",
            "parent": "136",
            "text": "2. Modelo en\notros ratones",
            "guid": "pKzqn8nWXl8Et0oNWdY5yw",
            "children": [
              {
                "id": "147",
                "parent": "146",
                "text": "• KO para péptido orexina:",
                "guid": "Q-2nDTuvO9LozWTU-F9mKA",
                "children": [
                  {
                    "id": "148",
                    "parent": "147",
                    "text": "• Fenotipo NT1 (53).",
                    "guid": "bK8QkjuiW50HDQkQJzY_xg",
                    "children": []
                  }
                ]
              },
              {
                "id": "149",
                "parent": "146",
                "text": "• Ratones con transgén Ataxina-3\nneurotóxica en neuronas orexinérgicas:",
                "guid": "CEZT6TTisq91aUoQkpzmJQ",
                "children": [
                  {
                    "id": "150",
                    "parent": "149",
                    "text": "• Mimetizan NT1\nhumano (53).",
                    "guid": "IjDascgNA1o2WUc0GUo4KQ",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "151",
            "parent": "136",
            "text": "3. Función diferencial de\nreceptores orexina",
            "guid": "Jd6RvI0Q-tik-O-jc2q3RA",
            "children": [
              {
                "id": "152",
                "parent": "151",
                "text": "• OX2R:",
                "guid": "",
                "children": [
                  {
                    "id": "153",
                    "parent": "152",
                    "text": "• Principal en regulación sueño/vigilia (54).",
                    "guid": "epYz4XIfb992vWW8r6Bl4w",
                    "children": []
                  }
                ]
              },
              {
                "id": "154",
                "parent": "151",
                "text": "• OX1R:",
                "guid": "",
                "children": [
                  {
                    "id": "155",
                    "parent": "154",
                    "text": "• Contribución menor.",
                    "guid": "Ke56vuuF94IDiovHZDGdMw",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "156",
            "parent": "136",
            "text": "4. Regulación por\nneuronas orexinérgicas",
            "guid": "OTTtUFD85hxCZMMFfql8DA",
            "children": [
              {
                "id": "157",
                "parent": "156",
                "text": "• Estimulación: Promueve transición sueño → vigilia (55).",
                "guid": "xDD5zDgWA0yyybyKIpzTTg",
                "children": []
              },
              {
                "id": "158",
                "parent": "156",
                "text": "• Silenciamiento: Induce sueño (56).",
                "guid": "s5Ke63o7OUWUpjJ6gadoXQ",
                "children": []
              }
            ]
          },
          {
            "id": "159",
            "parent": "136",
            "text": "5. Supresión del\nsueño REM",
            "guid": "aThewRhRJ8KXbmHHJ2nF8A",
            "children": [
              {
                "id": "160",
                "parent": "159",
                "text": "• Ambos receptores\n(OX1R y OX2R):",
                "guid": "",
                "children": [
                  {
                    "id": "161",
                    "parent": "160",
                    "text": "• Inhiben REM vía vías\nneuronales diferentes.",
                    "guid": "rnY7JSsRsZYgHtOfiFe4wA",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "id": "162",
        "parent": "0",
        "text": "Orexina y narcolepsia en\nhumanos y perros",
        "guid": "fED4-7xZOrftjZSeTI4Fsg",
        "children": [
          {
            "id": "163",
            "parent": "162",
            "text": "1. Narcolepsia con\ncataplejía (NT1)",
            "guid": "QkUrwfmlujmBzE87vsac_A",
            "children": [
              {
                "id": "164",
                "parent": "163",
                "text": "• Definición:",
                "guid": "",
                "children": [
                  {
                    "id": "165",
                    "parent": "164",
                    "text": "• Narcolepsia tipo 1 (NT1).",
                    "guid": "KAyLUyjhDuanxdrAFqLl8A",
                    "children": []
                  }
                ]
              },
              {
                "id": "166",
                "parent": "163",
                "text": "• Síntomas principales:",
                "guid": "",
                "children": [
                  {
                    "id": "167",
                    "parent": "166",
                    "text": "• EDS: Somnolencia diurna excesiva.",
                    "guid": "NdIy1s-7HyryED780-CGDw",
                    "children": []
                  },
                  {
                    "id": "168",
                    "parent": "166",
                    "text": "• Cataplejía: Pérdida súbita de tono muscular periférico (excepto\nmúsculos respiratorios) desencadenada por emociones.",
                    "guid": "o7aemK_gtBTJbTmSobJmug",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "169",
            "parent": "162",
            "text": "2. Patogenia de NT1",
            "guid": "Xkc6E52a-11QwrDhjW1GOA",
            "children": [
              {
                "id": "170",
                "parent": "169",
                "text": "• En humanos:",
                "guid": "",
                "children": [
                  {
                    "id": "171",
                    "parent": "170",
                    "text": "• ↓OX-A en LCR → Pérdida de neuronas\nproductoras de orexina (46, 47).",
                    "guid": "BTKP9q1LsXm9vQMewv0zag",
                    "children": []
                  },
                  {
                    "id": "172",
                    "parent": "170",
                    "text": "• Característica diagnóstica: ↓OX-A en\nLCR → Biomarcador para NT1.",
                    "guid": "Qk8RPdWmK--OZlKqrtas9w",
                    "children": []
                  },
                  {
                    "id": "173",
                    "parent": "170",
                    "text": "• Origen probable: Autoinmunidad (50).",
                    "guid": "13nNb4cF1fGhbOSt-lpQ8g",
                    "children": []
                  }
                ]
              },
              {
                "id": "174",
                "parent": "169",
                "text": "• En perros:",
                "guid": "Kw33EVYU8o8YzsHH0HBpEg",
                "children": [
                  {
                    "id": "175",
                    "parent": "174",
                    "text": "• Mutación genética → OX2R no funcional (49).",
                    "guid": "DWRdWiUnVBrv3Ba-zyCkiA",
                    "children": []
                  }
                ]
              },
              {
                "id": "176",
                "parent": "169",
                "text": "• No asociado a mutaciones en\nprepro-orexina ni OX2R en humanos.",
                "guid": "ZADlTMuUTfx2MiXEDBxVWQ",
                "children": []
              }
            ]
          },
          {
            "id": "177",
            "parent": "162",
            "text": "3. Fenotipo narcoléptico",
            "guid": "aUUNBl9_mBqwxD0swr8T3g",
            "children": [
              {
                "id": "178",
                "parent": "177",
                "text": "• Modelo murino:",
                "guid": "",
                "children": [
                  {
                    "id": "179",
                    "parent": "178",
                    "text": "• Ratones KO para orexina → Fenotipo similar a NT1 (p. ej., “cataplejía murina”)\n(48).",
                    "guid": "xKoItZ3qCnv5iUe4GO4eeg",
                    "children": []
                  }
                ]
              },
              {
                "id": "180",
                "parent": "177",
                "text": "• Manifestaciones en\nNT1:",
                "guid": "zRb8u5WW3UR_vseKKGWnPA",
                "children": [
                  {
                    "id": "181",
                    "parent": "180",
                    "text": "• Transiciones rápidas vigilia → REM.",
                    "guid": "9eHxzQ2ZGzAR1aSKd7jvRA",
                    "children": []
                  },
                  {
                    "id": "182",
                    "parent": "180",
                    "text": "• Fragmentación severa del sueño.",
                    "guid": "m8WINhl0PJYIHgicoYznpw",
                    "children": []
                  },
                  {
                    "id": "183",
                    "parent": "180",
                    "text": "• Parálisis del sueño.",
                    "guid": "jsz-tQAhnk-7pMU_2nnNsA",
                    "children": []
                  },
                  {
                    "id": "184",
                    "parent": "180",
                    "text": "• EDS crónica.",
                    "guid": "wyr-EIXmoT8KLLgPwVvlrw",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "185",
            "parent": "162",
            "text": "4. Importancia del\nsistema orexinérgico",
            "guid": "xEDJ-jp1N_wPm4YXVCgT7A",
            "children": [
              {
                "id": "186",
                "parent": "185",
                "text": "• Función clave: Estabilización de estados sueño/vigilia.",
                "guid": "_oS8Z-Ic_0cZAcuIvcICAA",
                "children": []
              },
              {
                "id": "187",
                "parent": "185",
                "text": "• Alteración: Disregulación severa sin efectos estabilizadores de orexina.",
                "guid": "KKUfRtmDr0QFH2t9P3al4Q",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "188",
        "parent": "0",
        "text": "Moduladores de\nreceptores orexina",
        "guid": "qEosWDsuIV22IL4zBC_7TQ",
        "children": [
          {
            "id": "189",
            "parent": "188",
            "text": "1. Desarrollo\nfarmacológico",
            "guid": "P9XKVsc5g6DyfTlk1Ew_Zg",
            "children": [
              {
                "id": "190",
                "parent": "189",
                "text": "• Causalidad NT1:",
                "guid": "",
                "children": [
                  {
                    "id": "191",
                    "parent": "190",
                    "text": "• ↓Orexina en NT1 humano y deficiencia OX2R en perros\n→ Modelos murinos replican NT1 (48, 53, 54, 57).",
                    "guid": "of-CMq4lLjYEXvJoSX7ULg",
                    "children": []
                  }
                ]
              },
              {
                "id": "192",
                "parent": "189",
                "text": "• Antagonistas de\nreceptores orexina\n(DORAs):",
                "guid": "",
                "children": [
                  {
                    "id": "193",
                    "parent": "192",
                    "text": "• Inicio: Programas de\ndescubrimiento desde 2000.",
                    "guid": "wgKvfGeqJaCS4xCqtUp0Jw",
                    "children": []
                  },
                  {
                    "id": "194",
                    "parent": "192",
                    "text": "• Prueba de concepto: Almorexant en\ninsomnio primario (2009) (58).",
                    "guid": "9-ZQ-kc0GHxYjqcbKVqGzQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "195",
                "parent": "189",
                "text": "• Actualidad:",
                "guid": "",
                "children": [
                  {
                    "id": "196",
                    "parent": "195",
                    "text": "• Suvorexant (2014) (59).",
                    "guid": "XKfXWGUhLt2BW3w7kEkOlg",
                    "children": []
                  },
                  {
                    "id": "197",
                    "parent": "195",
                    "text": "• Lemborexant (2019) (60).",
                    "guid": "oyya2Gd01jnW97E53hsjHQ",
                    "children": []
                  },
                  {
                    "id": "198",
                    "parent": "195",
                    "text": "• Daridorexant (2022) (61).",
                    "guid": "vlsWbe1Qf9aN7ijtR6qNUQ",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "199",
            "parent": "188",
            "text": "2. Mecanismo de\nacción de DORAs",
            "guid": "Vf-DKG6gah0BuSQheAcFxw",
            "children": [
              {
                "id": "200",
                "parent": "199",
                "text": "• OX2R: Principal objetivo.",
                "guid": "uvFnE3mUGaJS_OCOLW2VSg",
                "children": []
              },
              {
                "id": "201",
                "parent": "199",
                "text": "• Evidencia:",
                "guid": "",
                "children": [
                  {
                    "id": "202",
                    "parent": "201",
                    "text": "• Eficaces en ratones OX1R KO → ↑REM.",
                    "guid": "K7i5yko1EbK5k4Aq9Ksu-g",
                    "children": []
                  },
                  {
                    "id": "203",
                    "parent": "201",
                    "text": "• Sin efecto hipnótico en OX2R KO o\ndoble KO (OX1R/OX2R) (62).",
                    "guid": "C5GoyleHMY_5FbxUPEn2rA",
                    "children": []
                  }
                ]
              },
              {
                "id": "204",
                "parent": "199",
                "text": "• Comparación con\notros hipnóticos:",
                "guid": "",
                "children": [
                  {
                    "id": "205",
                    "parent": "204",
                    "text": "• DORAs: ↑REM.",
                    "guid": "uUGprJ29YrNikjn2jSs72w",
                    "children": []
                  },
                  {
                    "id": "206",
                    "parent": "204",
                    "text": "• Z-drugs, benzodiacepinas: ↑NREM, ↓REM.",
                    "guid": "zy0VuEqY5vC4XCk8qjUciw",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "207",
            "parent": "188",
            "text": "3. Indicaciones y\nefectos secundarios",
            "guid": "lpSAMl24mf3AdKpPco4TWw",
            "children": [
              {
                "id": "208",
                "parent": "207",
                "text": "• Indicaciones: Insomnio en adultos y poblaciones mayores.",
                "guid": "yNbZDK44B2LVRnCOGMe95w",
                "children": []
              },
              {
                "id": "209",
                "parent": "207",
                "text": "• Contraindicaciones: NT1 (riesgo de cataplejía, raro en uso clínico) (64).",
                "guid": "exB8YiKB2HiLF-8VmuioeQ",
                "children": []
              }
            ]
          },
          {
            "id": "210",
            "parent": "188",
            "text": "4. Antagonistas\nselectivos",
            "guid": "kdJPlvWN9ldFb4GV5_nRwA",
            "children": [
              {
                "id": "211",
                "parent": "210",
                "text": "• OX1R\nantagonistas:",
                "guid": "Ui4Q5B8yC7kF3yjx5jhEPg",
                "children": [
                  {
                    "id": "212",
                    "parent": "211",
                    "text": "• Ejemplo: JNJ-54717793 → Sin efecto en sueño.",
                    "guid": "PGlsMBh3B4d69PGTd9kLWA",
                    "children": []
                  },
                  {
                    "id": "213",
                    "parent": "211",
                    "text": "• Usos: Efecto ansiolítico/antipánico (68, 69).",
                    "guid": "O3H_75Gyu2IvyE0xrEqVKQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "214",
                "parent": "210",
                "text": "• OX2R\nantagonistas\n(2-SORAs):",
                "guid": "",
                "children": [
                  {
                    "id": "215",
                    "parent": "214",
                    "text": "• Ejemplo: Seltorexant, MK-1064 → Restauran sueño fisiológico\n(↑NREM y REM) (65, 70).",
                    "guid": "f3dpJvUEHeASB8el3qAf4g",
                    "children": []
                  },
                  {
                    "id": "216",
                    "parent": "214",
                    "text": "• Usos: Hipnóticos con efectos antidepresivos.",
                    "guid": "Gc6UHG24bEZEwf-aU-iZRw",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "217",
            "parent": "188",
            "text": "5. Ventajas de\nantagonistas de\norexina",
            "guid": "2xoUwKxWMNhDbpE1dL1AXw",
            "children": [
              {
                "id": "218",
                "parent": "217",
                "text": "• Memoria: Sin efectos negativos comparado con hipnóticos clásicos (71–74).",
                "guid": "FfY7rqv9DyCIzfIaovcIsw",
                "children": []
              },
              {
                "id": "219",
                "parent": "217",
                "text": "• Despertar: Más fácil en comparación con hipnóticos tradicionales (75, 76).",
                "guid": "6xlEAGSH8kOePznfSW1n3A",
                "children": []
              },
              {
                "id": "220",
                "parent": "217",
                "text": "• Tolerancia/dependencia: No evidenciada tras estudios prolongados (14 meses con suvorexant).",
                "guid": "NOdiC4aqYpTGD4-DNbLENw",
                "children": []
              },
              {
                "id": "221",
                "parent": "217",
                "text": "• Abuso: Menor potencial que hipnóticos clásicos (77).",
                "guid": "vpuSp-HYc_S-hpdvY57TVg",
                "children": []
              }
            ]
          },
          {
            "id": "222",
            "parent": "188",
            "text": "6. Agonistas\nselectivos OX2R",
            "guid": "rDHHDIoTs-MdRSRI_3Awew",
            "children": [
              {
                "id": "223",
                "parent": "222",
                "text": "• Ejemplos:",
                "guid": "",
                "children": [
                  {
                    "id": "224",
                    "parent": "223",
                    "text": "• TAK-925 (danavorexón, IV).",
                    "guid": "EXzMgDRHW1Rst6rlX82kQQ",
                    "children": []
                  },
                  {
                    "id": "225",
                    "parent": "223",
                    "text": "• TAK-994 (firazorexón, oral).",
                    "guid": "Ji1bQGNf-EMVO147vVUdpQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "226",
                "parent": "222",
                "text": "• Usos en NT1:",
                "guid": "",
                "children": [
                  {
                    "id": "227",
                    "parent": "226",
                    "text": "• Normalizan patrones sueño-vigilia.",
                    "guid": "XL7l3iDGETlGKPSNl-xwsA",
                    "children": []
                  },
                  {
                    "id": "228",
                    "parent": "226",
                    "text": "• Bloquean ataques de cataplejía (78–80).",
                    "guid": "KBxQpsWD2_KKk_cje6u6KA",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "id": "229",
        "parent": "0",
        "text": "Sueño en el\nenvejecimiento\nsaludable",
        "guid": "dumrR2LY_NuYC8NSBf7a7Q",
        "children": [
          {
            "id": "230",
            "parent": "229",
            "text": "1. Cambios en el sueño a\nlo largo de la vida",
            "guid": "6OAwGyab-U-zdlT_k2OsSQ",
            "children": [
              {
                "id": "231",
                "parent": "230",
                "text": "• Infancia:",
                "guid": "",
                "children": [
                  {
                    "id": "232",
                    "parent": "231",
                    "text": "• Sueño: Hasta 17 h/día en períodos de 2–4 h (81).",
                    "guid": "zVBwqL_ppF51s04LQsL5gg",
                    "children": []
                  }
                ]
              },
              {
                "id": "233",
                "parent": "230",
                "text": "• Niñez temprana:",
                "guid": "",
                "children": [
                  {
                    "id": "234",
                    "parent": "233",
                    "text": "• Ritmo circadiano definido.",
                    "guid": "gb_1-ob7RxoqLKbw9Teg4A",
                    "children": []
                  },
                  {
                    "id": "235",
                    "parent": "233",
                    "text": "• Sueño: ≈12 h/día (82).",
                    "guid": "ZLy6tR6z1JztP9HNSSg9Ew",
                    "children": []
                  }
                ]
              },
              {
                "id": "236",
                "parent": "230",
                "text": "• Pubertad:",
                "guid": "",
                "children": [
                  {
                    "id": "237",
                    "parent": "236",
                    "text": "• ↓Latencia REM y SWS comparado con la infancia (83).",
                    "guid": "5jrGGUazPeckiYLjaaCoUQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "238",
                "parent": "230",
                "text": "• Adultez temprana:",
                "guid": "",
                "children": [
                  {
                    "id": "239",
                    "parent": "238",
                    "text": "• Sueño consolidado.",
                    "guid": "F60B3WKJLYp-AqVNo_IyNg",
                    "children": []
                  },
                  {
                    "id": "240",
                    "parent": "238",
                    "text": "• ↓TST comparado con adolescentes.",
                    "guid": "KTf5Ld2XLMOn226MggA4dg",
                    "children": []
                  }
                ]
              },
              {
                "id": "241",
                "parent": "230",
                "text": "• >50 años:",
                "guid": "",
                "children": [
                  {
                    "id": "242",
                    "parent": "241",
                    "text": "• Cambios característicos (3):",
                    "guid": "So8my5x9nh-zuJndW6UwBA",
                    "children": []
                  },
                  {
                    "id": "243",
                    "parent": "241",
                    "text": "• ↑Latencia para dormir.",
                    "guid": "oeBNYacg8O1DVSTAH8wOZg",
                    "children": []
                  },
                  {
                    "id": "244",
                    "parent": "241",
                    "text": "• ↓TST.",
                    "guid": "HBKt461sYjG_-uD93HLJ3g",
                    "children": []
                  },
                  {
                    "id": "245",
                    "parent": "241",
                    "text": "• Sueño fragmentado con más despertares nocturnos.",
                    "guid": "HYOEa6WW2kS6IkUF_EkmcA",
                    "children": []
                  },
                  {
                    "id": "246",
                    "parent": "241",
                    "text": "• ↓Ciclos de sueño.",
                    "guid": "OYge5VEiMan6t5nQoyizWQ",
                    "children": []
                  },
                  {
                    "id": "247",
                    "parent": "241",
                    "text": "• ↓SWS → Compensación con ↑NREM N1 y N2.",
                    "guid": "FnUZq2acsc1BCFH-ZWKcjQ",
                    "children": []
                  },
                  {
                    "id": "248",
                    "parent": "241",
                    "text": "• Alteraciones en procesos homeostáticos (S) y circadianos (C) (85).",
                    "guid": "6m2zBv80etNtYmVNxheqoA",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "249",
            "parent": "229",
            "text": "2. Debate sobre necesidad\nde sueño en ancianos",
            "guid": "42AHcGTzm5d0mszPawTkxA",
            "children": [
              {
                "id": "250",
                "parent": "249",
                "text": "• Teoría 1 (menos\nnecesidad):",
                "guid": "",
                "children": [
                  {
                    "id": "251",
                    "parent": "250",
                    "text": "• ↓Impulso homeostático → ↓Sueño compensatorio tras privación (86, 87).",
                    "guid": "-4e-_wU-yR36GBIBW2RBVA",
                    "children": []
                  }
                ]
              },
              {
                "id": "252",
                "parent": "249",
                "text": "• Teoría 2 (igual\nnecesidad):",
                "guid": "",
                "children": [
                  {
                    "id": "253",
                    "parent": "252",
                    "text": "• ↑Problemas en generación y sensibilidad al sueño.",
                    "guid": "vAYek9JPoP0E_UCXbCnicg",
                    "children": []
                  }
                ]
              },
              {
                "id": "254",
                "parent": "249",
                "text": "• Evidencia:",
                "guid": "",
                "children": [
                  {
                    "id": "255",
                    "parent": "254",
                    "text": "• ↑EDS y siestas vespertinas.",
                    "guid": "dDKhx8xewQGQzYy7pGLfCg",
                    "children": []
                  },
                  {
                    "id": "256",
                    "parent": "254",
                    "text": "• ↓Aprendizaje y consolidación de memoria dependientes del sueño (88, 89).",
                    "guid": "uj8OKo8yj1qQ9VcUz-yxOA",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "257",
            "parent": "229",
            "text": "3. Cambios funcionales en\ncircuitos del sueño",
            "guid": "8qCAtPeN4e6cLvdedGEYvA",
            "children": [
              {
                "id": "258",
                "parent": "257",
                "text": "• Declive\nneurofuncional:",
                "guid": "l9DL4Z0KJ_umIojCKrYRhg",
                "children": [
                  {
                    "id": "259",
                    "parent": "258",
                    "text": "• ↓Receptores de adenosina en SNC (90).",
                    "guid": "qaG903X3Olj85ylC7f1NTQ",
                    "children": []
                  },
                  {
                    "id": "260",
                    "parent": "258",
                    "text": "• ↓Neuronas galaninérgicas en VLPO (91).",
                    "guid": "o2pTfRUDawZNLDzgN1VmYw",
                    "children": []
                  },
                  {
                    "id": "261",
                    "parent": "258",
                    "text": "• ↓Activación de α-2 adrenorreceptores (92).",
                    "guid": "RGphzZAOXKhqpjStQRo0uQ",
                    "children": []
                  },
                  {
                    "id": "262",
                    "parent": "258",
                    "text": "• ↓Células neuronales en SCN y pituitaria (93).",
                    "guid": "37d5Y6IZLVMVy2dEmg6fMw",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "263",
            "parent": "229",
            "text": "4. Alteraciones en el\nsistema ARAS y orexina",
            "guid": "E-2Ke5Qx9OQfyTm35ij6UA",
            "children": [
              {
                "id": "264",
                "parent": "263",
                "text": "• ARAS:",
                "guid": "",
                "children": [
                  {
                    "id": "265",
                    "parent": "264",
                    "text": "• ↓Neuronas productoras de orexina con la edad (94–96).",
                    "guid": "Zo7qkl2mnUKbCLaz_8S3CQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "266",
                "parent": "263",
                "text": "• Disfunción\norexinérgica:",
                "guid": "lRosVmjKI0orhzg96702OQ",
                "children": [
                  {
                    "id": "267",
                    "parent": "266",
                    "text": "• Ratones\nviejos:",
                    "guid": "_7cScT5HF2HIAp5456pz-w",
                    "children": [
                      {
                        "id": "268",
                        "parent": "267",
                        "text": "• ↑Actividad basal de neuronas orexinérgicas durante vigilia.",
                        "guid": "ACodtMhuuM7s9qRPkvZIaQ",
                        "children": []
                      },
                      {
                        "id": "269",
                        "parent": "267",
                        "text": "• ↓Expresión del canal K+ KCNQ subunidad 2 → Umbral de excitabilidad alterado (96).",
                        "guid": "__NOAa1dJTPHZo_DIUoEJQ",
                        "children": []
                      },
                      {
                        "id": "270",
                        "parent": "267",
                        "text": "• Estimulación optogenética → ↑Vigilia más marcada en ratones viejos.",
                        "guid": "1LdVs9uVOiT9rS-pxsasGA",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "271",
                    "parent": "266",
                    "text": "• Importancia: Plasticidad neurofarmacológica del ARAS\n→ Salud y bienestar en envejecimiento (97).",
                    "guid": "533sa-cqEvaszCp0vrchHw",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "id": "272",
        "parent": "0",
        "text": "Ensayos clínicos de antagonistas\nde receptores orexina (DORAs) en\npersonas mayores",
        "guid": "3YjHirLKEm8vEO_UcoN-lg",
        "children": [
          {
            "id": "273",
            "parent": "272",
            "text": "1. Generalidades de los\nensayos clínicos",
            "guid": "H5abaduNYra9IT4uLUV9nw",
            "children": [
              {
                "id": "274",
                "parent": "273",
                "text": "• DORAs evaluados:",
                "guid": "",
                "children": [
                  {
                    "id": "275",
                    "parent": "274",
                    "text": "• Suvorexant, lemborexant, daridorexant.",
                    "guid": "NxVqTNmUwzEDCzAo-LKunw",
                    "children": []
                  }
                ]
              },
              {
                "id": "276",
                "parent": "273",
                "text": "• Principal indicación: Insomnio en adultos mayores (>65 años).",
                "guid": "kAGc3ewelMsKMnPJ3NDfGA",
                "children": []
              },
              {
                "id": "277",
                "parent": "273",
                "text": "• Poblaciones\nadicionales:",
                "guid": "",
                "children": [
                  {
                    "id": "278",
                    "parent": "277",
                    "text": "• Apnea del sueño, EA, ISWRD, delirium, caídas.",
                    "guid": "gsY5ObtAPiBollMtSzTKIQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "279",
                "parent": "273",
                "text": "• Diseño: Estudios aleatorizados, doble ciego, placebo-controlados; seguimiento ≥3 meses.",
                "guid": "47gmijBI7pyFS4Ri2TP0bw",
                "children": []
              }
            ]
          },
          {
            "id": "280",
            "parent": "272",
            "text": "2. Hallazgos en insomnio\ngeriátrico (Tablas 1 y 2)",
            "guid": "GLfPgdgo5XRWNrBMFfwKUg",
            "children": [
              {
                "id": "281",
                "parent": "280",
                "text": "• Efectos\nprincipales:",
                "guid": "DlsDIWUVt2VzgqHrVtYaiw",
                "children": [
                  {
                    "id": "282",
                    "parent": "281",
                    "text": "• TST: ↑ en comparación con placebo.",
                    "guid": "spSSNu4TJHamIJYAQuRrjQ",
                    "children": []
                  },
                  {
                    "id": "283",
                    "parent": "281",
                    "text": "• WASO y LPS: ↓ dosis-dependiente.",
                    "guid": "jVyiO85dO4-eZDRQQTGpLQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "284",
                "parent": "280",
                "text": "• Tolerancia y\nseguridad:",
                "guid": "_1blPhEfX3NJ1N1fKkM-MQ",
                "children": [
                  {
                    "id": "285",
                    "parent": "284",
                    "text": "• Eventos adversos comunes: Somnolencia matutina (dependiente de dosis, ↑ en >75 años).",
                    "guid": "_nQUI85AJxfYIWn2rPTlLQ",
                    "children": []
                  },
                  {
                    "id": "286",
                    "parent": "284",
                    "text": "• Comparables en eficacia a adultos jóvenes.",
                    "guid": "c0ev5DzGVeLj3as4NRGizg",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "287",
            "parent": "272",
            "text": "3. Suvorexant en EA\ncon insomnio (ADI)",
            "guid": "1VYVyxlzIoibt-1w1N40rg",
            "children": [
              {
                "id": "288",
                "parent": "287",
                "text": "• PSG en ADI (117, 179):",
                "guid": "",
                "children": [
                  {
                    "id": "289",
                    "parent": "288",
                    "text": "• ↓SWS, ↑N1, ↓Spindles en N2, ↓EEG NREM, ↓REM.",
                    "guid": "W3Ux_EQgrd1Uj5IyU6S-uA",
                    "children": []
                  }
                ]
              },
              {
                "id": "290",
                "parent": "287",
                "text": "• Estudio clínico pivotal\n(179, 180):",
                "guid": "N6E0FGLpV_aM4P_9xYh0kw",
                "children": [
                  {
                    "id": "291",
                    "parent": "290",
                    "text": "• Diseño: 4 semanas, doble ciego, placebo-controlado, EA leve-moderada.",
                    "guid": "4sngqqyILBMSP7Ac4dalMg",
                    "children": []
                  }
                ]
              },
              {
                "id": "292",
                "parent": "287",
                "text": "• Resultados:",
                "guid": "",
                "children": [
                  {
                    "id": "293",
                    "parent": "292",
                    "text": "• TST y WASO: Mejoras significativas.",
                    "guid": "oj7pl7Pq-sVAqOzRCqpCYw",
                    "children": []
                  },
                  {
                    "id": "294",
                    "parent": "292",
                    "text": "• Aprobación FDA: Tratamiento de insomnio en ADI.",
                    "guid": "pVX2J_cmIAslvYRnowWl8w",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "295",
            "parent": "272",
            "text": "4. Lemborexant en\nEA con ISWRD",
            "guid": "PjI2jZmYHks2KnFvVJLH7w",
            "children": [
              {
                "id": "296",
                "parent": "295",
                "text": "• Estudio\nexploratorio fase II\n(183):",
                "guid": "",
                "children": []
              },
              {
                "id": "297",
                "parent": "295",
                "text": "• Población: EA\ncon ISWRD.",
                "guid": "",
                "children": []
              },
              {
                "id": "298",
                "parent": "295",
                "text": "• Diseño: 4 semanas, doble\nciego, placebo-controlado.",
                "guid": "",
                "children": []
              },
              {
                "id": "299",
                "parent": "295",
                "text": "• Mediciones:",
                "guid": "",
                "children": []
              },
              {
                "id": "300",
                "parent": "295",
                "text": "• Actigrafía: Ritmo circadiano, sueño\nnocturno, actividad diurna.",
                "guid": "",
                "children": []
              },
              {
                "id": "301",
                "parent": "295",
                "text": "• Cognición:\nMMSE,\nADAS-Cog.",
                "guid": "",
                "children": []
              },
              {
                "id": "302",
                "parent": "295",
                "text": "• Resultados:",
                "guid": "",
                "children": []
              },
              {
                "id": "303",
                "parent": "295",
                "text": "• Mejoras dependientes de\ndosis y duración en síntomas\nnocturnos y diurnos.",
                "guid": "",
                "children": []
              },
              {
                "id": "304",
                "parent": "295",
                "text": "• Limitación: Grupos pequeños\n(12–13 sujetos/grupo).",
                "guid": "",
                "children": []
              }
            ]
          },
          {
            "id": "305",
            "parent": "272",
            "text": "5. DORAs en delirium",
            "guid": "eRX_fkeqtcYIzhHtHTFBTw",
            "children": [
              {
                "id": "306",
                "parent": "305",
                "text": "• Suvorexant:",
                "guid": "",
                "children": []
              },
              {
                "id": "307",
                "parent": "305",
                "text": "• Estudios en UCI y postoperatorio (181, 182):\n↓Incidencia de delirium comparado con\nplacebo o agonistas GABA-A.",
                "guid": "",
                "children": []
              }
            ]
          },
          {
            "id": "308",
            "parent": "272",
            "text": "6. Estudios en curso",
            "guid": "n4kVfCNa4aPkYX3SF9X8ew",
            "children": [
              {
                "id": "309",
                "parent": "308",
                "text": "• 2-SORAs (seltorexant):",
                "guid": "",
                "children": []
              },
              {
                "id": "310",
                "parent": "308",
                "text": "• Indicaciones: Depresión\nresistente, probable EA.",
                "guid": "",
                "children": []
              },
              {
                "id": "311",
                "parent": "308",
                "text": "• Actualmente: Sin reportes\npublicados en adultos mayores.",
                "guid": "",
                "children": []
              }
            ]
          },
          {
            "id": "312",
            "parent": "272",
            "text": "7. Conclusiones",
            "guid": "-bJnhIvDVknme1y3P7UCxQ",
            "children": [
              {
                "id": "313",
                "parent": "312",
                "text": "• Evidencia acumulada: DORAs efectivos en\ninsomnio geriátrico y ADI → Mejora TST,\nWASO y ritmos circadianos.",
                "guid": "",
                "children": []
              },
              {
                "id": "314",
                "parent": "312",
                "text": "• Investigación futura: Extender\nestudios en tauopatías y 2-SORAs.",
                "guid": "",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "315",
        "parent": "0",
        "text": "Conclusión",
        "guid": "6X9y0XwpQ8l3O7v22_EEgg",
        "children": [
          {
            "id": "316",
            "parent": "315",
            "text": "1. Importancia del sueño",
            "guid": "kV-irnN35X2N8wy4EcFYhQ",
            "children": [
              {
                "id": "317",
                "parent": "316",
                "text": "• Funciones: Cognición,\nmemoria, regulación biológica.",
                "guid": "",
                "children": []
              },
              {
                "id": "318",
                "parent": "316",
                "text": "• Impacto del envejecimiento:\n↓Calidad y cantidad → ↑Riesgos\nasociados a privación de sueño.",
                "guid": "",
                "children": []
              }
            ]
          },
          {
            "id": "319",
            "parent": "315",
            "text": "2. Estrategias\nterapéuticas",
            "guid": "17GIYMw25suznnq3biNMqQ",
            "children": [
              {
                "id": "320",
                "parent": "319",
                "text": "• No farmacológicas:",
                "guid": "",
                "children": []
              },
              {
                "id": "321",
                "parent": "319",
                "text": "• CBTI (terapia cognitivo-conductual\npara insomnio): Primera línea;\ndesafíos en adherencia (184).",
                "guid": "",
                "children": []
              },
              {
                "id": "322",
                "parent": "319",
                "text": "• Terapia de luz, ejercicio.",
                "guid": "",
                "children": []
              },
              {
                "id": "323",
                "parent": "319",
                "text": "• Farmacológicas:",
                "guid": "",
                "children": []
              },
              {
                "id": "324",
                "parent": "319",
                "text": "• DORAs:",
                "guid": "",
                "children": []
              },
              {
                "id": "325",
                "parent": "319",
                "text": "• Favorables en\nenvejecimiento y EA.",
                "guid": "",
                "children": []
              },
              {
                "id": "326",
                "parent": "319",
                "text": "• ↑REM → Mantienen\narquitectura natural del sueño.",
                "guid": "",
                "children": []
              },
              {
                "id": "327",
                "parent": "319",
                "text": "• ↓Riesgo de\ncaídas nocturnas.",
                "guid": "",
                "children": []
              }
            ]
          },
          {
            "id": "328",
            "parent": "315",
            "text": "3. Relación sueño-EA",
            "guid": "Otw7wL6FYdzZQnrOAva2Qw",
            "children": [
              {
                "id": "329",
                "parent": "328",
                "text": "• Interacciones\nbidireccionales:",
                "guid": "",
                "children": []
              },
              {
                "id": "330",
                "parent": "328",
                "text": "• Privación de sueño → ↑Aβ,\n↑Tau, neuroinflamación, aparición\ntemprana de EA/FTD.",
                "guid": "",
                "children": []
              },
              {
                "id": "331",
                "parent": "328",
                "text": "• Tratamiento temprano en MCI/EA →\nPotencial para retrasar progresión.",
                "guid": "",
                "children": []
              }
            ]
          },
          {
            "id": "332",
            "parent": "315",
            "text": "4. Evidencia actual",
            "guid": "O6uKFCj6c88DaPjaON6j7w",
            "children": [
              {
                "id": "333",
                "parent": "332",
                "text": "• Suvorexant y\nlemborexant:",
                "guid": "",
                "children": []
              },
              {
                "id": "334",
                "parent": "332",
                "text": "• Efectos subcrónicos:\nMejoras parciales en sueño en\nadultos mayores y EA.",
                "guid": "",
                "children": []
              },
              {
                "id": "335",
                "parent": "332",
                "text": "• Pendiente: Confirmar impacto a largo\nplazo y en disrupciones cognitivas.",
                "guid": "",
                "children": []
              }
            ]
          },
          {
            "id": "336",
            "parent": "315",
            "text": "5. Preguntas clave",
            "guid": "gitFouuXPteie3UXS28jXA",
            "children": [
              {
                "id": "337",
                "parent": "336",
                "text": "• Inicio del tratamiento:",
                "guid": "",
                "children": []
              },
              {
                "id": "338",
                "parent": "336",
                "text": "• Identificar el momento óptimo para\nretrasar/revertir progresión de EA.",
                "guid": "",
                "children": []
              },
              {
                "id": "339",
                "parent": "336",
                "text": "• Ensayos en curso:\nResponderán estas\ninterrogantes.",
                "guid": "",
                "children": []
              }
            ]
          },
          {
            "id": "340",
            "parent": "315",
            "text": "6. Impacto potencial",
            "guid": "Ej3fajSlEwK43fDaohFW5Q",
            "children": [
              {
                "id": "341",
                "parent": "340",
                "text": "• Beneficios:",
                "guid": "",
                "children": []
              },
              {
                "id": "342",
                "parent": "340",
                "text": "• Mejorar sueño en envejecimiento\ny EA → ↑Calidad de vida para\npacientes y cuidadores.",
                "guid": "",
                "children": []
              },
              {
                "id": "343",
                "parent": "340",
                "text": "• ↓Carga para\nsistemas de salud.",
                "guid": "",
                "children": []
              }
            ]
          }
        ]
      }
    ]
  },
  "node_count": 344,
  "relations": [],
  "cross_references": [],
  "specialty": "General",
  "folder": "- Entidades clínicas/Cardiología",
  "filename": "Antagonstas del receptor de Orexina-2025",
  "id": "map_1176",
  "resolved_references": []
}